Overview: The NADF, established in 1985, stands as a not-for-profit 501(c)(3) organization, ID #11-2777036, committed to serving the adrenal disease community. With a vision for a world free from suffering or fatalities due to adrenal disease, NADF has dedicated itself to providing life-preserving information and guidance approved by medical advisors. Boasting a membership of over 10,000 individuals, NADF oversees close to 20 Support Groups led by trained volunteers.

In 2021, NADF launched the International Adrenal Diseases Patient Organization Consortium, fostering collaborative efforts with like-minded entities. Emphasizing partnerships with patient organizations, industry collaborators, and medical associations, NADF actively engages in educational programs, webinars, conferences, and various events. Furthermore, NADF champions research initiatives, sponsoring critical projects such as the Adrenal Insufficiency (MyAI) Registry, MyAI Cortisol and Function Study, and MyAI DNA and Cortisol Study.

NADF’s Mission: Advance education, support, and research to enhance the lives of those affected by adrenal disease.